Identification of Novel Candidate Biomarkers for Oral Squamous Cell Carcinoma Based on Whole Gene Expression Profiling

Overview

Journal Pathol Oncol Res

Specialty Oncology

Date 2020 May 30

PMID 32468250

Citations 10

Authors

Sudaporn Kengkarn

Songsak Petmitr

Usa Boonyuen

Onrapak Reamtong

Sopee Poomsawat

Sirima Sanguansin

Affiliations

Soon will be listed here.

Abstract

This study aimed to determine the whole gene expression profiles and to ascertain potential biomarkers for 22 oral squamous cell carcinoma (OSCC) among Thai patients using the Illumina Human HT-12, V4.0 Expression BeadChip array. Result indicated 2,724 differential expressed genes composed of 1,560 up-regulated and 1,164 down-regulated genes (unpaired t-test, p-value <0.05; fold change ≥2.0 and ≤2.0). The top 9 up-regulated genes were validated in 39 OSCC cases using TaqMan real-time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) assay. Among these, the up-regulation of peptidase inhibitor 3 (PI3) and keratin 17 (KRT17) genes was harbored in all 39 OSCC patients (100%). Likewise, statistical analysis indicated that gene expression in 8 selective genes including keratin 16 (KRT16), keratin 14 (KRT14), keratinocyte differentiation-associated protein (KRTDAP), keratin 6B (KRT6B), PI3, S100 calcium binding protein A7 (S100A7), stratifin (SFN) and keratin 5 (KRT5) was significantly associated with well differentiated OSCC (p-value <0.05). Moreover, high level of KRT17 protein was significantly associated with well differentiated OSCC compared to moderately OSCC (p-value = 0.041). Notably, using nested-PCR analysis indicated all OSCC cases in this study were HPV-free. Especially, KRTDAP, PI3, SFN mRNA expression were first reported among patients with OSCC. Conclusion, the whole transcript expression study and TaqMan real-time qRT-PCR assay were relevant regarding the increase in gene expression in OSCC. In addition, the up-regulation of PI3 and KRT17 might constitute potential candidate molecular biomarkers to diagnose patients with OSCC.

Citing Articles

Plasmonics-enhanced spikey nanorattle-based biosensor for direct SERS detection of mRNA cancer biomarkers.

Li J, Atta S, Zhao Y, Hoang K, Canning A, Strobbia P Anal Bioanal Chem. 2024; 416(30):7347-7355.

PMID: 39373917 DOI: 10.1007/s00216-024-05549-6.

Keratins 6, 16, and 17 in Health and Disease: A Summary of Recent Findings.

Romashin D, Tolstova T, Varshaver A, Kozhin P, Rusanov A, Luzgina N Curr Issues Mol Biol. 2024; 46(8):8627-8641.

PMID: 39194725 PMC: 11352355. DOI: 10.3390/cimb46080508.

Tetraspanin CD82 Correlates with and May Regulate S100A7 Expression in Oral Cancer.

Reddi K, Zhang W, Shahrabi-Farahani S, Anderson K, Liu M, Kakhniashvili D Int J Mol Sci. 2024; 25(5).

PMID: 38473906 PMC: 10932236. DOI: 10.3390/ijms25052659.

Liquid biopsy: an examination of platelet RNA obtained from head and neck squamous cell carcinoma patients for predictive molecular tumor markers.

Huber L, Kraus J, Ezic J, Wanli A, Groth M, Laban S Explor Target Antitumor Ther. 2023; 4(3):422-446.

PMID: 37455825 PMC: 10344902. DOI: 10.37349/etat.2023.00143.

Transcriptomic Profile of Canine Mammary Ductal Carcinoma.

Santos D, Fernandez G, Pardini L, Pardini M, Ferrasi A Int J Mol Sci. 2023; 24(6).

PMID: 36982287 PMC: 10049542. DOI: 10.3390/ijms24065212.

References

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

Brinkman B, Wong D . Disease mechanism and biomarkers of oral squamous cell carcinoma. Curr Opin Oncol. 2006; 18(3):228-33. DOI: 10.1097/01.cco.0000219250.15041.f8. View

Mendez E, Cheng C, Farwell D, Ricks S, Agoff S, Futran N . Transcriptional expression profiles of oral squamous cell carcinomas. Cancer. 2002; 95(7):1482-94. DOI: 10.1002/cncr.10875. View

Tomioka H, Morita K, Hasegawa S, Omura K . Gene expression analysis by cDNA microarray in oral squamous cell carcinoma. J Oral Pathol Med. 2006; 35(4):206-11. DOI: 10.1111/j.1600-0714.2006.00410.x. View

Wang Y, Tian X, Liu O, Fang X, Quan H, Xie S . Gene profiling analysis for patients with oral verrucous carcinoma and oral squamous cell carcinoma. Int J Clin Exp Med. 2014; 7(7):1845-52. PMC: 4132153. View

Chakrabarti S, Multani S, Dabholkar J, Saranath D . Whole genome expression profiling in chewing-tobacco-associated oral cancers: a pilot study. Med Oncol. 2015; 32(3):60. DOI: 10.1007/s12032-015-0483-4. View

Khovidhunkit S, Buajeeb W, Sanguansin S, Poomsawat S, Weerapradist W . Detection of human papillomavirus in oral squamous cell carcinoma, leukoplakia and lichen planus in Thai patients. Asian Pac J Cancer Prev. 2009; 9(4):771-5. View

Nopmaneepaisarn T, Tangjaturonrasme N, Rawangban W, Vinayanuwattikun C, Keelawat S, Bychkov A . Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience. BMC Cancer. 2019; 19(1):1050. PMC: 6836494. DOI: 10.1186/s12885-019-6266-0. View

Bhattacharjee A, Richards W, Staunton J, Li C, Monti S, Vasa P . Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A. 2001; 98(24):13790-5. PMC: 61120. DOI: 10.1073/pnas.191502998. View

10.

Welsh J, Zarrinkar P, Sapinoso L, Kern S, Behling C, Monk B . Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci U S A. 2001; 98(3):1176-81. PMC: 14728. DOI: 10.1073/pnas.98.3.1176. View

11.

Hunt K, Wingate H, Yokota T, Liu Y, Mills G, Zhang F . Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer. Breast Cancer Res. 2013; 15(1):R3. PMC: 3672770. DOI: 10.1186/bcr3374. View

12.

Labidi-Galy S, Clauss A, Ng V, Duraisamy S, Elias K, Piao H . Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors. Oncogene. 2014; 34(3):373-83. PMC: 4112176. DOI: 10.1038/onc.2013.562. View

13.

Westin U, Nystrom M, Ljungcrantz I, Eriksson B, Ohlsson K . The presence of elafin, SLPI, IL1-RA and STNFalpha RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation. Mediators Inflamm. 2002; 11(1):7-12. PMC: 1781642. DOI: 10.1080/09629350210304. View

14.

Tsuchida S, Bonkobara M, McMillan J, Akiyama M, Yudate T, Aragane Y . Characterization of Kdap, a protein secreted by keratinocytes. J Invest Dermatol. 2004; 122(5):1225-34. DOI: 10.1111/j.0022-202X.2004.22511.x. View

15.

Thibodeau B, Geddes T, Fortier L, Ahmed S, Pruetz B, Wobb J . Gene Expression Characterization of HPV Positive Head and Neck Cancer to Predict Response to Chemoradiation. Head Neck Pathol. 2014; 9(3):345-53. PMC: 4542789. DOI: 10.1007/s12105-014-0597-6. View

16.

Kesting M, Sudhoff H, Hasler R, Nieberler M, Pautke C, Wolff K . Psoriasin (S100A7) up-regulation in oral squamous cell carcinoma and its relation to clinicopathologic features. Oral Oncol. 2009; 45(8):731-6. DOI: 10.1016/j.oraloncology.2008.11.012. View

17.

Kong F, Li Y, Hu E, Wang R, Wang J, Liu J . The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma. PLoS One. 2016; 11(12):e0167080. PMC: 5132200. DOI: 10.1371/journal.pone.0167080. View

18.

Chen J, He Q, Yuen A, Chiu J . Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis. Proteomics. 2004; 4(8):2465-75. DOI: 10.1002/pmic.200300762. View

19.

Ren H, Pan G, Wang J, Wen J, Wang K, Luo G . Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma. Dig Dis Sci. 2010; 55(9):2552-60. DOI: 10.1007/s10620-009-1065-0. View

20.

Mirza S, Sharma G, Parshad R, Srivastava A, Gupta S, Ralhan R . Clinical significance of Stratifin, ERalpha and PR promoter methylation in tumor and serum DNA in Indian breast cancer patients. Clin Biochem. 2009; 43(4-5):380-6. DOI: 10.1016/j.clinbiochem.2009.11.016. View